MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 5.56
-0.01 (-0.18%)
Jun 3, 2026, 2:00 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.93 billion as of June 3, 2026. Its market cap has decreased by -8.26% in one year.
Market Cap
2.93B
Enterprise Value
3.21B
Revenue
635.85M
Ranking
n/a
PE Ratio
70.25
Stock Price
5.56
Market Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.93B, a decrease of -33.07%. That is a compound annual growth rate of -15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 2.91B | 19.21% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 334.09B |
| Caliway Biopharmaceuticals | 150.19B |
| Lotus Pharmaceutical | 51.51B |
| Heron Neutron Medical | 50.96B |
| Intech Biopharm | 3.00B |
| Chunghwa Chemical Synthesis & Biotech | 2.99B |
| Genovate Biotechnology | 2.95B |
| GlycoNex Incorporation | 2.95B |